Advertisement
GEN vs MDPEF
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GEN is a Buy and MDPEF is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
GEN’s FA Score shows that 3 FA rating(s) are green whileMDPEF’s FA Score has 1 green FA rating(s).
- GEN’s FA Score: 3 green, 2 red.
- MDPEF’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
GEN’s TA Score shows that 6 TA indicator(s) are bullish.
- GEN’s TA Score: 6 bullish, 4 bearish.
Price Growth
GEN (@Computer Communications) experienced а +11.44% price change this week, while MDPEF (@Services to the Health Industry) price change was 0.00% for the same time period.
The average weekly price growth across all stocks in the @Computer Communications industry was +2.41%. For the same industry, the average monthly price growth was -0.63%, and the average quarterly price growth was +23.68%.
The average weekly price growth across all stocks in the @Services to the Health Industry industry was +1.48%. For the same industry, the average monthly price growth was -0.22%, and the average quarterly price growth was +2.81%.
Reported Earning Dates
GEN is expected to report earnings on Oct 30, 2025.
Industries' Descriptions
@Computer Communications (+2.41% weekly)Computer communications industry develops technology that allows computing devices to exchange data with each other using connections/data links between nodes. Common types of computer network include Cloud (IAN), Internet, Wide (WAN, Local (LAN)/Wireless(WLAN) etc. The industry is an ever-more important part of technology, and is set to become even bigger as the Internet of Things (IoT) rapidly forays into the various aspects of our lives. Cisco Systems, Inc., Palo Alto Networks, Inc. and Arista Networks, Inc., Fortinet, Inc. are some of the major computer communications companies.
@Services to the Health Industry (+1.48% weekly)This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.
| GEN | MDPEF | GEN / MDPEF | |
| Capitalization | 19.6B | 103M | 19,029% |
| EBITDA | 2.03B | 3.08B | 66% |
| Gain YTD | 17.356 | 0.000 | - |
| P/E Ratio | 33.18 | 6.02 | 551% |
| Revenue | 3.94B | 13.4B | 29% |
| Total Cash | 1.01B | 7.16B | 14% |
| Total Debt | 8.32B | 2.9B | 287% |
GEN | ||
|---|---|---|
OUTLOOK RATING 1..100 | 84 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 19 Undervalued | |
PROFIT vs RISK RATING 1..100 | 44 | |
SMR RATING 1..100 | 34 | |
PRICE GROWTH RATING 1..100 | 26 | |
P/E GROWTH RATING 1..100 | 26 | |
SEASONALITY SCORE 1..100 | 75 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| GEN | MDPEF | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 67% | N/A |
| Stochastic ODDS (%) | 1 day ago 57% | N/A |
| Momentum ODDS (%) | 1 day ago 66% | N/A |
| MACD ODDS (%) | 1 day ago 63% | N/A |
| TrendWeek ODDS (%) | 1 day ago 66% | 1 day ago 12% |
| TrendMonth ODDS (%) | 1 day ago 64% | 1 day ago 11% |
| Advances ODDS (%) | 1 day ago 69% | N/A |
| Declines ODDS (%) | 12 days ago 64% | N/A |
| BollingerBands ODDS (%) | 1 day ago 70% | N/A |
| Aroon ODDS (%) | 1 day ago 61% | N/A |
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| GAB | 5.95 | 0.06 | +1.02% |
| Gabelli Equity Trust (The) | |||
| SPXX | 18.09 | 0.12 | +0.67% |
| Nuveen S&P 500 Dynamic Overwrite Fund | |||
| HOOX | 123.38 | 0.26 | +0.21% |
| Defiance Daily Target 2X Long HOOD ETF | |||
| DFND | 43.10 | N/A | N/A |
| Siren DIVCON Dividend Defender ETF | |||
| LCLG | 58.63 | N/A | N/A |
| Logan Capital Broad Innovative Gr ETF | |||
MDPEF and
Correlation & Price change
A.I.dvisor tells us that MDPEF and NUTX have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MDPEF and NUTX's prices will move in lockstep.
| Ticker / NAME | Correlation To MDPEF | 1D Price Change % | ||
|---|---|---|---|---|
| MDPEF | 100% | N/A | ||
| NUTX - MDPEF | 22% Poorly correlated | +7.24% | ||
| NEXOF - MDPEF | 22% Poorly correlated | -11.87% | ||
| GEN - MDPEF | 20% Poorly correlated | +3.51% | ||
| BTRCF - MDPEF | 14% Poorly correlated | N/A | ||
| IARGF - MDPEF | 0% Poorly correlated | N/A | ||
More | ||||